April 6, 2025 - 04:28

During Microsoft’s 50th anniversary celebration, the atmosphere was unexpectedly charged when two employees took the stage to voice their concerns regarding the company's deployment of artificial intelligence technology. The event, which was attended by both past and present CEOs, was intended to be a moment of reflection and celebration of the company's achievements over the decades.
The protestors raised critical questions about the ethical implications of AI technology, emphasizing the potential consequences of its unchecked use. Their actions sparked a heated discussion among attendees about the responsibilities of tech companies in the evolving landscape of artificial intelligence.
As the company reflects on its half-century legacy, the interruption served as a reminder of the growing scrutiny surrounding technology and its impact on society. The incident has prompted many within the industry to reconsider the balance between innovation and ethical responsibility, highlighting the need for ongoing dialogue about the future of AI.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...